ATE49763T1 - 1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine. - Google Patents

1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine.

Info

Publication number
ATE49763T1
ATE49763T1 AT84307974T AT84307974T ATE49763T1 AT E49763 T1 ATE49763 T1 AT E49763T1 AT 84307974 T AT84307974 T AT 84307974T AT 84307974 T AT84307974 T AT 84307974T AT E49763 T1 ATE49763 T1 AT E49763T1
Authority
AT
Austria
Prior art keywords
imidazo
carbon atoms
quinoline
group
quinolines
Prior art date
Application number
AT84307974T
Other languages
English (en)
Inventor
John F Gerster
Original Assignee
Riker Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Riker Laboratories Inc filed Critical Riker Laboratories Inc
Application granted granted Critical
Publication of ATE49763T1 publication Critical patent/ATE49763T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C07D215/42—Nitrogen atoms attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Physical Water Treatments (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Alarm Systems (AREA)
  • Quinoline Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Lubricants (AREA)
  • Luminescent Compositions (AREA)
AT84307974T 1983-11-18 1984-11-16 1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine. ATE49763T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US55315883A 1983-11-18 1983-11-18
US55315783A 1983-11-18 1983-11-18
EP84307974A EP0145340B1 (de) 1983-11-18 1984-11-16 1H-Imidazo(4,5c)chinoline und 1H-Imidazo(4,5-c)chinolin-4-amine

Publications (1)

Publication Number Publication Date
ATE49763T1 true ATE49763T1 (de) 1990-02-15

Family

ID=27070262

Family Applications (2)

Application Number Title Priority Date Filing Date
AT88116137T ATE84525T1 (de) 1983-11-18 1984-11-16 Chinolinzwischenprodukte fuer die synthese von 1h- imidazo(4,5-c>chinolinen und 1h-imidazo(4,5- c>chinolin-4-aminen.
AT84307974T ATE49763T1 (de) 1983-11-18 1984-11-16 1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT88116137T ATE84525T1 (de) 1983-11-18 1984-11-16 Chinolinzwischenprodukte fuer die synthese von 1h- imidazo(4,5-c>chinolinen und 1h-imidazo(4,5- c>chinolin-4-aminen.

Country Status (15)

Country Link
EP (2) EP0145340B1 (de)
JP (1) JPS60123488A (de)
KR (1) KR900005657B1 (de)
AT (2) ATE84525T1 (de)
AU (2) AU581190B2 (de)
CA (1) CA1271477A (de)
DE (3) DE3486043T2 (de)
DK (6) DK164280C (de)
ES (1) ES8603477A1 (de)
IE (1) IE57874B1 (de)
IL (2) IL84537A (de)
NL (2) NL980043I1 (de)
NO (7) NO163819C (de)
NZ (1) NZ210228A (de)
PH (1) PH22338A (de)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1306260C (en) * 1985-10-18 1992-08-11 Shionogi & Co., Ltd. Condensed imidazopyridine derivatives
US4942168A (en) * 1987-07-13 1990-07-17 Hoechst-Roussel Pharmaceuticals Inc. Hydroxyquinoline amines, and method of enhancing memory in mammals
CA1335996C (en) * 1988-02-16 1995-06-20 Susumu Takada 2-substituted carbonylimidazo¬4,5-c|quinolines
EP0361489A3 (de) * 1988-09-30 1991-06-12 Chugai Seiyaku Kabushiki Kaisha 3,4-Diaminochinolin- und Pyridinverbindungen
ES2094141T3 (es) * 1989-02-27 1997-01-16 Riker Laboratories Inc 1h-imidazo(4,5-c)quinolin-4-aminas como antivirales.
US4994468A (en) * 1989-03-07 1991-02-19 Kyowa Hakko Kogyo Co., Ltd. Imidazoquinolone derivatives
US4929624A (en) * 1989-03-23 1990-05-29 Minnesota Mining And Manufacturing Company Olefinic 1H-imidazo(4,5-c)quinolin-4-amines
CA2021338C (en) * 1989-07-18 1996-07-16 Fumio Suzuki Imidazoquinolone derivatives
US4988815A (en) * 1989-10-26 1991-01-29 Riker Laboratories, Inc. 3-Amino or 3-nitro quinoline compounds which are intermediates in preparing 1H-imidazo[4,5-c]quinolines
FR2654021B1 (fr) * 1989-11-07 1992-02-28 Simond Jacques Procede de vitrification de cendres volantes et dispositif pour sa mise en óoeuvre.
GB8928281D0 (en) * 1989-12-14 1990-02-21 Smith Kline French Lab Compounds
ES2094772T3 (es) * 1990-06-01 1997-02-01 Kyowa Hakko Kogyo Kk Derivados de imidazonaftiridinas.
DK0582581T3 (da) * 1991-03-01 1999-11-08 Minnesota Mining & Mfg 1,2-substituerede 1H-imidazo[4,5-c]quinolin-4-aminer
US5266575A (en) * 1991-11-06 1993-11-30 Minnesota Mining And Manufacturing Company 2-ethyl 1H-imidazo[4,5-ciquinolin-4-amines
IL105325A (en) * 1992-04-16 1996-11-14 Minnesota Mining & Mfg Immunogen/vaccine adjuvant composition
US5395937A (en) * 1993-01-29 1995-03-07 Minnesota Mining And Manufacturing Company Process for preparing quinoline amines
US5693811A (en) * 1996-06-21 1997-12-02 Minnesota Mining And Manufacturing Company Process for preparing tetrahdroimidazoquinolinamines
US6069149A (en) * 1997-01-09 2000-05-30 Terumo Kabushiki Kaisha Amide derivatives and intermediates for the synthesis thereof
JPH10298181A (ja) * 1997-04-25 1998-11-10 Sumitomo Pharmaceut Co Ltd タイプ２ヘルパーｔ細胞選択的免疫応答抑制剤
JP2000119271A (ja) 1998-08-12 2000-04-25 Hokuriku Seiyaku Co Ltd １ｈ―イミダゾピリジン誘導体
WO2003035626A2 (en) * 2001-10-23 2003-05-01 Applied Research Systems Ars Holding N.V. Azole derivatives and pharmaceutical compositions containing them
GB0211649D0 (en) * 2002-05-21 2002-07-03 Novartis Ag Organic compounds
KR20050028047A (ko) 2002-07-23 2005-03-21 비오갈 기오기스제르갸르 알티. 1ｈ-이미다조[4,5-ｃ]퀴놀린-4-프탈이미드 중간체를 통한1ｈ-이미다조[4,5-ｃ]퀴놀린-4-아민의 제조
CN100372847C (zh) 2002-07-26 2008-03-05 特瓦药厂私人有限公司 通过新的1h-咪唑并[4,5-c]喹啉-4-氰基和1h-咪唑并[4,5-c]喹啉-4-碳酰胺中间体制备1h-咪唑并[4,5-c]喹啉-4-胺
MXPA06001669A (es) 2003-08-12 2006-04-28 3M Innovative Properties Co Compuestos que contienen imidazo-oxima sustituidos.
US7897597B2 (en) * 2003-08-27 2011-03-01 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted imidazoquinolines
WO2005023190A2 (en) 2003-09-05 2005-03-17 3M Innovative Properties Company Treatment for cd5+ b cell lymphoma
WO2005033049A2 (en) 2003-10-01 2005-04-14 Taro Pharmaceuticals U.S.A., Inc. METHOD OF PREPARING 4-AMINO-1H-IMIDAZO(4,5-c)QUINOLINES AND ACID ADDITION SALTS THEREOF
US8871782B2 (en) * 2003-10-03 2014-10-28 3M Innovative Properties Company Alkoxy substituted imidazoquinolines
US7544697B2 (en) 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
ITMI20032121A1 (it) * 2003-11-04 2005-05-05 Dinamite Dipharma Spa In Forma Abbr Eviata Dipharm Procedimento per la preparazione di imiquimod e suoi intermedi
CA2545774A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Oxime substituted imidazo ring compounds
CA2545825A1 (en) 2003-11-14 2005-06-02 3M Innovative Properties Company Hydroxylamine substituted imidazo ring compounds
AU2004293078B2 (en) 2003-11-25 2012-01-19 3M Innovative Properties Company Substituted imidazo ring systems and methods
EP1701955A1 (de) 2003-12-29 2006-09-20 3M Innovative Properties Company Arylalkenyl- und arylalkinylsubstituierte imidazochinoline
CA2551399A1 (en) 2003-12-30 2005-07-21 3M Innovative Properties Company Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
EP1730143A2 (de) 2004-03-24 2006-12-13 3M Innovative Properties Company Amidsubstituierte imidazopyridine, imidazochinoline und imidazonaphthyridine
WO2005123080A2 (en) 2004-06-15 2005-12-29 3M Innovative Properties Company Nitrogen-containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
WO2006038923A2 (en) 2004-06-18 2006-04-13 3M Innovative Properties Company Aryl substituted imidazonaphthyridines
WO2006009826A1 (en) 2004-06-18 2006-01-26 3M Innovative Properties Company Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
US7915281B2 (en) 2004-06-18 2011-03-29 3M Innovative Properties Company Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
JP5313502B2 (ja) 2004-12-30 2013-10-09 スリーエム イノベイティブ プロパティズ カンパニー 置換キラル縮合［１，２］イミダゾ［４，５−ｃ］環状化合物
AU2005322898B2 (en) 2004-12-30 2011-11-24 3M Innovative Properties Company Chiral fused (1,2)imidazo(4,5-c) ring compounds
AU2006210392A1 (en) 2005-02-04 2006-08-10 Coley Pharmaceutical Group, Inc. Aqueous gel formulations containing immune response modifiers
JP2008530113A (ja) 2005-02-11 2008-08-07 コーリー ファーマシューティカル グループ，インコーポレイテッド オキシムおよびヒドロキシラミン置換イミダゾ［４，５−ｃ］環化合物および方法
WO2006107851A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. 1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
AU2006232377A1 (en) 2005-04-01 2006-10-12 Coley Pharmaceutical Group, Inc. Pyrazolopyridine-1,4-diamines and analogs thereof
ES2577514T3 (es) 2005-08-22 2016-07-15 The Regents Of The University Of California Antagonistas de TLR
CA2653941C (en) 2006-05-31 2013-01-08 The Regents Of The University Of California Substituted amino purine derivatives and uses thereof
US7906506B2 (en) 2006-07-12 2011-03-15 3M Innovative Properties Company Substituted chiral fused [1,2] imidazo [4,5-c] ring compounds and methods
SI2510946T1 (sl) 2007-02-07 2015-12-31 The Regents Of The University Of California Konjugati sintetičnih agonistov TLR in njihove uporabe
EP2009002A1 (de) * 2007-06-21 2008-12-31 Institut National De La Sante Et De La Recherche Medicale (Inserm) Neues Verfahren zur Herstellung von 1H-imidazo [4,5-c]-chinolin-Ringsystemen
WO2010088924A1 (en) 2009-02-06 2010-08-12 Telormedix Sa Pharmaceutical compositions comprising imidazoquinolin(amines) and derivatives thereof suitable for local administration
MX2011008500A (es) 2009-02-11 2011-09-26 Univ California Moduladores del receptor tipo toll y tratamiento de enfermedades.
EP3222621B1 (de) * 2010-08-17 2023-03-08 3M Innovative Properties Company Lipidierte immunantwort-modifizierende verbindung und ihre medizinische verwendung
US8728486B2 (en) 2011-05-18 2014-05-20 University Of Kansas Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
WO2013052550A2 (en) * 2011-10-04 2013-04-11 Janus Biotherapeutics, Inc. Novel imidazole quinoline-based immune system modulators
BR112015018282B1 (pt) * 2013-02-01 2021-08-24 Wellstat Therapeutics Corporation Compostos de amina, composição compreendendo os referidos compostos e usos dos mesmos
CN105189495A (zh) * 2013-03-15 2015-12-23 先正达参股股份有限公司 新颖的杀微生物剂
ES2538880B1 (es) * 2013-12-24 2016-09-08 Laboratorios Viñas S.A. Un procedimiento para obtener 4-amino-1-isobutil-1H-imidazo[4,5-c]quinoleína
EP3092254A4 (de) 2014-01-10 2017-09-20 Birdie Biopharmaceuticals Inc. Verbindungen und zusammensetzungen zur behandlung von her2-positiven tumoren
DK3166976T3 (da) 2014-07-09 2022-04-11 Birdie Biopharmaceuticals Inc Anti-pd-l1-kombinationer til behandling af tumorer
CN108137586B (zh) * 2015-09-14 2021-04-13 辉瑞大药厂 作为LRRK2抑制剂的新颖咪唑并[4,5-c]喹啉和咪唑并[4,5-c][1,5]萘啶衍生物
CN106943597A (zh) 2016-01-07 2017-07-14 博笛生物科技（北京）有限公司 用于治疗肿瘤的抗-egfr组合
CN115554406A (zh) 2016-01-07 2023-01-03 博笛生物科技有限公司 用于治疗肿瘤的抗-cd20组合
US10533007B2 (en) 2016-04-19 2020-01-14 Innate Tumor Immunity, Inc. NLRP3 modulators
SG11201809082WA (en) 2016-04-19 2018-11-29 Innate Tumor Immunity Inc Nlrp3 modulators
US11697851B2 (en) 2016-05-24 2023-07-11 The Regents Of The University Of California Early ovarian cancer detection diagnostic test based on mRNA isoforms
TWI674261B (zh) 2017-02-17 2019-10-11 美商英能腫瘤免疫股份有限公司 Nlrp3 調節劑
CN108794467A (zh) 2017-04-27 2018-11-13 博笛生物科技有限公司 2-氨基-喹啉衍生物
CA3067268A1 (en) 2017-06-23 2018-12-27 Birdie Biopharmaceuticals, Inc. Crystalline resiquimod monosulfate anhydrate and its preparation and uses
FR3113287B1 (fr) 2020-08-07 2023-06-23 Phv Pharma Procédé industriel de synthèse de l’imiquimod à partir de la quinolèine-2,4-diol applicable à son utilisation pharmaceutique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700674A (en) * 1969-04-30 1972-10-24 American Cyanamid Co 4-alkylamino-3-nitroquinolines
RO86850B (ro) * 1982-05-03 1985-05-31 Eli Lilly And Company Procedeu pentru prepararea unor 2-fenilimidazo [4,5 c] piridine

Also Published As

Publication number Publication date
EP0145340A2 (de) 1985-06-19
DK542684D0 (da) 1984-11-15
EP0310950A1 (de) 1989-04-12
NO890822L (no) 1985-05-20
DK135791D0 (da) 1991-07-16
NO890825D0 (no) 1989-02-27
DK164280C (da) 1992-11-30
DK165921B (da) 1993-02-08
NL980043I1 (nl) 1999-02-01
DK164280B (da) 1992-06-01
NO169437C (no) 1992-06-24
NO169437B (no) 1992-03-16
ES537677A0 (es) 1985-12-16
NO844565L (no) 1985-05-20
NO165145B (no) 1990-09-24
EP0145340B1 (de) 1990-01-24
IE842952L (en) 1985-05-18
ATE84525T1 (de) 1993-01-15
DK169179B1 (da) 1994-09-05
CA1271477A (en) 1990-07-10
DK136091D0 (da) 1991-07-16
NO890824L (no) 1985-05-20
NL980041I2 (nl) 1999-07-01
DK136191D0 (da) 1991-07-16
IL84537A0 (en) 1988-04-29
NO165147C (no) 1991-01-02
NO890822D0 (no) 1989-02-27
NO165147B (no) 1990-09-24
NL980041I1 (nl) 1999-02-01
AU3540284A (en) 1985-05-23
DK135891D0 (da) 1991-07-16
NZ210228A (en) 1989-01-27
DK136091A (da) 1991-07-16
AU611997B2 (en) 1991-06-27
EP0145340A3 (en) 1986-06-11
NO168705B (no) 1991-12-16
JPS60123488A (ja) 1985-07-02
ES8603477A1 (es) 1985-12-16
NO890825L (no) 1985-05-20
DK135991A (da) 1991-07-16
NO890824D0 (no) 1989-02-27
DE3486043D1 (de) 1993-02-25
AU581190B2 (en) 1989-02-16
NO165146C (no) 1991-01-02
DE3486043T2 (de) 1993-06-03
NO890823L (no) 1985-05-20
DK165921C (da) 1993-06-28
DK135891A (da) 1991-07-16
IL84537A (en) 1990-12-23
IE57874B1 (en) 1993-05-05
KR900005657B1 (ko) 1990-08-03
DK164452C (da) 1992-11-09
DK164452B (da) 1992-06-29
EP0310950B1 (de) 1993-01-13
NO165145C (no) 1991-01-02
DK164455B (da) 1992-06-29
DK164451B (da) 1992-06-29
KR850003890A (ko) 1985-06-29
NO165146B (no) 1990-09-24
DK135991D0 (da) 1991-07-16
PH22338A (en) 1988-08-12
NO890823D0 (no) 1989-02-27
JPH0586391B2 (de) 1993-12-10
NO163819B (no) 1990-04-17
NO890826D0 (no) 1989-02-27
DK164451C (da) 1992-11-09
NO1999015I1 (no) 1999-07-08
DK135791A (da) 1991-07-16
DK136191A (da) 1991-07-16
DK542684A (da) 1985-05-19
NO890826L (no) 1985-05-20
NO168705C (no) 1992-03-25
NO163819C (no) 1990-08-01
DE19975027I2 (de) 2000-09-21
AU2991189A (en) 1989-06-15
DK164455C (da) 1992-11-16
DE3481124D1 (de) 1990-03-01

Similar Documents

Publication Publication Date Title
ATE49763T1 (de) 1h-imidazo(4,5c)chinoline und 1h-imidazo(4,5c)chinolin-4-amine.